Aethlon Medical Inc. (AEMD)
NASDAQ: AEMD
· Real-Time Price · USD
1.13
-0.04 (-3.42%)
At close: Aug 15, 2025, 2:33 PM
-3.42% (1D)
| Bid | 1.13 |
| Market Cap | 2.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -13.39M |
| EPS (ttm) | -8.58 |
| PE Ratio (ttm) | -0.13 |
| Forward PE | -0.61 |
| Analyst | Hold |
| Ask | 1.16 |
| Volume | 43,618 |
| Avg. Volume (20D) | 271,494 |
| Open | 1.18 |
| Previous Close | 1.17 |
| Day's Range | 1.11 - 1.18 |
| 52-Week Range | 1.09 - 8.48 |
| Beta | 1.72 |
About AEMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AEMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AEMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-35.57%
Aethlon Medical shares are trading lower after the...
Unlock content with
Pro Subscription
6 months ago
+19.08%
Aethlon Medical shares are trading higher after the company announced it treated its first patient in the Australian Hemopurifier cancer trial.
